Smith & Nephew (NYSE:SNN) Rating Lowered to Buy at StockNews.com

Smith & Nephew (NYSE:SNN) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday.

Other equities research analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft downgraded Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Berenberg Bank cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold”.

Smith & Nephew Stock Up 0.1 %

Shares of NYSE SNN opened at $24.61 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The stock has a 50 day moving average price of $29.12 and a 200 day moving average price of $27.87. Smith & Nephew has a 52 week low of $23.65 and a 52 week high of $31.72.

Hedge Funds Weigh In On Smith & Nephew

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Mather Group LLC. increased its stake in shares of Smith & Nephew by 9,735.3% during the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock worth $42,000 after purchasing an additional 1,655 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Smith & Nephew by 1,894.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in Smith & Nephew by 92.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after buying an additional 1,179 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Smith & Nephew by 160.0% during the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock worth $70,000 after buying an additional 1,389 shares in the last quarter. Finally, Headlands Technologies LLC boosted its position in shares of Smith & Nephew by 225.0% in the first quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock valued at $98,000 after acquiring an additional 2,666 shares during the period. 25.64% of the stock is owned by institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.